Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Magnesium Sulfate in FESS
NCT06966102Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lidocaine Hydrochloride Injection, without epinephrine and magnesium sulfate in perioperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Intraoperative fentanyl consumption at 5 hours. Planned start May 2025; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinemagnesium sulfate
03
Conditions
perioperative pain
Beyond the preview
Go deeper on NCT06966102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966102.